Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) updated its FY25 earnings guidance on Thursday. The company provided EPS guidance of $4.40-4.46 for the period, compared to the consensus EPS estimate of $4.40. The company issued revenue guidance of $1.13-1.14 billion, compared to the consensus revenue estimate of $1.13 billion. Prestige Consumer Healthcare also updated its FY 2025 guidance to 4.400-4.460 EPS.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. StockNews.com downgraded Prestige Consumer Healthcare from a strong-buy rating to a buy rating in a research report on Tuesday, May 21st. DA Davidson reiterated a buy rating and set a $93.00 price objective on shares of Prestige Consumer Healthcare in a research report on Friday. Finally, Canaccord Genuity Group reiterated a buy rating and set a $80.00 price objective on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average price target of $98.25.
View Our Latest Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Trading Down 0.9 %
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. The company had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same quarter in the previous year, the business earned $1.06 earnings per share. The company’s revenue for the quarter was down 4.4% on a year-over-year basis. On average, equities analysts anticipate that Prestige Consumer Healthcare will post 4.42 EPS for the current fiscal year.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Further Reading
- Five stocks we like better than Prestige Consumer Healthcare
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 8/5 – 8/9
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.